The company's focus is on creating a pipeline of novel CNS therapeutics through internal R&D and strategic partnerships, utilizing targets that are supported by human biology to increase the likelihood of success in clinical development. SciNeuro is committed to transforming scientific discoveries into groundbreaking therapies that can improve the lives of patients worldwide, with an established pipeline of therapeutic candidates to address neurodegenerative and other CNS diseases.